Jefferies analyst Chris Lui maintained a Buy rating on Shandong Weigao Group Medical Polymer Co (SHWGF – Research Report) yesterday and set a price target of HK$17.00. The company’s shares closed last Friday at $0.96.
Lui covers the Healthcare sector, focusing on stocks such as Innovent Biologics, The United Laboratories International Holdings, and Alibaba Health Information Technology. According to TipRanks, Lui has an average return of -14.1% and a 26.83% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Shandong Weigao Group Medical Polymer Co with a $2.18 average price target.
See the top stocks recommended by analysts >>
SHWGF market cap is currently $4.34B and has a P/E ratio of 12.32.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Shandong Weigao Group Medical Polymer Co (SHWGF) Company Description:
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.
